BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30851710)

  • 1. CD24
    Xu C; Zhang M; Li K; Ni M; Bai Y; Zhang J; Song X; Wang J
    Int Immunopharmacol; 2019 May; 70():295-301. PubMed ID: 30851710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-L1
    Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
    Front Immunol; 2018; 9():2241. PubMed ID: 30327652
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic obstructive pulmonary disease is characterized by reduced levels and defective suppressive function of regulatory B cells in peripheral blood.
    Lin S; Ma Z; Huang Y; Sun Y; Yi H
    Mol Immunol; 2022 Jan; 141():87-93. PubMed ID: 34837778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficit of circulating CD19
    Zaimoku Y; Patel BA; Kajigaya S; Feng X; Alemu L; Quinones Raffo D; Groarke EM; Young NS
    Br J Haematol; 2020 Aug; 190(4):610-617. PubMed ID: 32311088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19
    Zhang Y; Wei S; Wu Q; Shen X; Dai W; Zhang Z; Chen M; Huang H; Ma L
    Clin Rheumatol; 2022 Aug; 41(8):2403-2416. PubMed ID: 35420296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
    Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
    Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24
    Körber N; Pohl L; Weinberger B; Grubeck-Loebenstein B; Wawer A; Knolle PA; Roggendorf H; Protzer U; Bauer T
    Front Immunol; 2021; 12():713351. PubMed ID: 34566969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD24
    Hasan MM; Thompson-Snipes L; Klintmalm G; Demetris AJ; O'Leary J; Oh S; Joo H
    J Immunol; 2019 Oct; 203(8):2110-2120. PubMed ID: 31511354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of CD19
    Zhao Q; Jung LK
    Pediatr Rheumatol Online J; 2018 Jul; 16(1):44. PubMed ID: 29973221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD19
    Chen Q; Lai L; Chi X; Lu X; Wu H; Sun J; Wu W; Cai L; Zeng X; Wang C; Chen W; Peng A
    Mediators Inflamm; 2020; 2020():3019378. PubMed ID: 32104147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease in the proportion of CD24
    Wang Y; Qin Y; Wang X; Zhang L; Wang J; Xu X; Chen H; Hsu HT; Zhang M
    Clin Exp Immunol; 2020 Apr; 200(1):22-32. PubMed ID: 31849037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies.
    Aybar LT; McGregor JG; Hogan SL; Hu Y; Mendoza CE; Brant EJ; Poulton CJ; Henderson CD; Falk RJ; Bunch DO
    Clin Exp Immunol; 2015 May; 180(2):178-88. PubMed ID: 25376552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis.
    Kim Y; Kim G; Shin HJ; Hyun JW; Kim SH; Lee E; Kim HJ
    J Neuroinflammation; 2018 Oct; 15(1):300. PubMed ID: 30373595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correlation of CD19 + CD24 + CD38 + B cells and other clinicopathological variables with the proportion of circulating Tregs in breast cancer patients.
    Gheybi MK; Farrokhi S; Ravanbod MR; Ostovar A; Mehrzad V; Nematollahi P
    Breast Cancer; 2017 Nov; 24(6):756-764. PubMed ID: 28429331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased number of CD19
    Li T; Yu Z; Qu Z; Zhang N; Crew R; Jiang Y
    Mol Immunol; 2019 Aug; 112():233-239. PubMed ID: 31181422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and Immunophenotypic Characterization of Human CD24
    Alhabbab RY; Lombardi G
    Methods Mol Biol; 2021; 2270():451-467. PubMed ID: 33479913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Gαq impairs regulatory B-cell function.
    He Y; Yuan X; Li Y; Zhong C; Liu Y; Qian H; Xuan J; Duan L; Shi G
    Arthritis Res Ther; 2018 Aug; 20(1):186. PubMed ID: 30143054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences.
    Lin W; Jin L; Chen H; Wu Q; Fei Y; Zheng W; Wang Q; Li P; Li Y; Zhang W; Zhao Y; Zeng X; Zhang F
    Arthritis Res Ther; 2014 May; 16(3):R118. PubMed ID: 24887143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral CD19+CD24
    Piloni D; Morosini M; Magni S; Balderacchi A; Inghilleri S; Cova E; Oggionni T; Frangipane V; Pandolfi L; Scudeller L; Meloni F
    Transpl Immunol; 2019 Dec; 57():101245. PubMed ID: 31526864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease.
    de Masson A; Bouaziz JD; Le Buanec H; Robin M; O'Meara A; Parquet N; Rybojad M; Hau E; Monfort JB; Branchtein M; Michonneau D; Dessirier V; Sicre de Fontbrune F; Bergeron A; Itzykson R; Dhédin N; Bengoufa D; Peffault de Latour R; Xhaard A; Bagot M; Bensussan A; Socié G
    Blood; 2015 Mar; 125(11):1830-9. PubMed ID: 25605369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.